News.
Stay up to date with the latest news about our innovation initiatives
Published on 24/10/2023
AlmirallShare opens new call for proposals
We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.
AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
